LOX and neoplasm: Using mouse and human colorectal tumor models as well as genetic and pharmacologic inhibition of LOX activity, we determined that the effect of inhibition of LOX activity on colorectal tumorigenesis depends on LOX-derived metabolites in both the tumor cells and the host stroma.